Clinical Trial Update: REVERSE-AKI Randomized Controlled Pilot Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized pilot trial (REVERSE-AKI) focusing on acute kidney injury in critically ill patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Kidney Injury

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Acute Kidney Injury, Critical Illness | Phase 2 | Status: COMPLETED